YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Wei-Li Shao, President of Omada Health (NASDAQ:OMDA), sold 9,418 shares of the company on Aug. 12, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value $236,000 Shares sold 9,418 Post-transactio…
Chief Executive Officer Sean P. Duffy reported the disposition of 31,457 shares of Omada Health, Inc. (NASDAQ:OMDA) on Sept. 1, 2026, according to a recent SEC Form 4 filing. Transaction summary Metric Value Transaction value ~$735,150 Sha…
Teladoc Health, Inc.'s TDOC Integrated Care is increasingly becoming the more dependable part of the business. Its growth is modest, but the segment is becoming more profitable as chronic care gains traction. That matters because Teladoc's…
Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Vice President and Chief Accounting Officer - Craig Gracey Co-founder and Chief Executive Officer - Sean Duffy President - Wei-Li Shao Chief Finan…
Key Points Interested in Omada Health, Inc.? Here are five stocks we like better. Omada Health reported record second-quarter results, with revenue rising 43% year over year to $88 million, gross margin reaching 74% and adjusted EBITDA tot…
Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base. Continue Reading
Omada Health (NASDAQ:OMDA), a digital care platform for chronic conditions, disclosed that Chief Executive Officer Sean P. Duffy sold 17,258 shares in multiple open-market transactions from June 24 through June 26, 2026, as reported in the…
Omada Health, Inc. OMDA shares ended the last trading session 10.5% higher at $20.89. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 6.1% gain o…
The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 28% rise over the past year, while earnings are projected to grow by 17% annually. In such an environment, identifying stocks that m…
On May 14, 2026, Archon Capital Management disclosed in a Securities and Exchange Commission (SEC) filing that it sold out its entire position in Babcock & Wilcox Enterprises(NYSE:BW), liquidating 1,325,045 shares for an estimated $13.93 m…
On May 14, 2026, Archon Capital Management disclosed a new position in Oceaneering International(NYSE:OII), acquiring 208,000 shares in a transaction estimated at $6.73 million based on quarterly average pricing. What happened According to…
On May 14, 2026, Archon Capital Management disclosed it sold out its entire EZCORP(NASDAQ:EZPW) stake, an estimated $8.81 million transaction based on quarterly average pricing. What happened According to its SEC filing dated May 14, 2026,…
Key Points Archon Capital Management exited a position in EZCORP last quarter, selling its 367,433 shares. As a result, the quarter-end position value decreased by $7.14 million. EZCORP previously represented 4.1% of fund AUM in the prior…
Archon Capital Management opened a new position in Satellogic(NASDAQ:SATL), acquiring 1,647,687 shares in the first quarter for an estimated $6.07 million based on quarterly average pricing, according to a May 14, 2026, SEC filing. What ha…
Key Points Archon Capital Management bought 1,647,687 shares of Satellogic in the first quarter; the estimated trade size was $6.07 million (based on quarterly average prices). Meanwhile, the quarter-end position value increased by $8.96 m…
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Omda's fair value price target of NOK 57.0 is unchanged, providing a steady reference point while assumptions around discount rates…
Earnings Call Insights: Omada Health (OMDA) Q1 2026 MANAGEMENT VIEW * "Q1 2026 was a milestone quarter for Omada" with "42% revenue growth" and "a guidance raise," according to CEO Sean Duffy (Co-Founder, CEO & Director), who also highligh…
IPO stock Omada Health easily beat first-quarter sales expectations Thursday, and announced a deal with drug titan Eli Lilly. Continue Reading
Omada Health, Inc. Survey of more than 3,000 GLP‑1 patients reveals care gaps and rising out‑of‑pocket costs, underscoring employers’ need to pair flexible GLP‑1 access with ongoing lifestyle support SAN FRANCISCO, May 07, 2026 (GLOBE NEWS…
Over the last 7 days, the United States market has risen by 1.3% and is up 35% over the past year, with earnings expected to grow by 16% annually in the coming years. In this environment of robust growth, identifying stocks that are potent…
Key Points Omada Health's digital healthcare platform helps patients between doctors visits, improving outcomes. A growing trove of data shows the company's success in improving its members' health -- especially those on GLP-1s. Omada grew…
Founder-led digital healthcare upstart Omada Health (NASDAQ: OMDA) was launched to deliver between-visit guidance to patients with chronic conditions such as hypertension, high cholesterol, diabetes, obesity, or musculoskeletal problems. I…
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Omda’s Fair Value price target has been reaffirmed at NOK 59.0, keeping the core valuation anchor s…
Earnings Call Insights: Omada Health, Inc. (OMDA) Q4 2025 MANAGEMENT VIEW * CEO Sean Duffy described 2025 as a “milestone year,” highlighting the company’s public debut, 53% annual revenue growth, and first quarter of GAAP profitability. D…
Omada Health logo Key Points First GAAP profitable quarter: Omada reported Q4 2025 GAAP net income of $5 million and full-year revenue of $260 million (up 53%), with membership up 55% to 886,000 and sustained margin expansion (Q4 adjusted…
Key Points Liberty Street Advisors, Inc. increased its stake in Voyager Technologies by 136,925 shares; the estimated trade size was $3.71 million based on average quarterly pricing. Meanwhile, the quarter-end value of the Voyager Technolo…
Key Points Liberty Street Advisors, Inc. increased its stake in Voyager Technologies by 136,925 shares; the estimated trade size was $3.71 million based on average quarterly pricing. Meanwhile, the quarter-end value of the Voyager Technolo…
Key Points Liberty Street Advisors added 999,202 shares of BETA in the fourth quarter. The estimated value was $28.19 million. The transaction resulted in the BETA position accounting for 47.15% of the fund's reportable assets under manage…
Key Points Liberty Street Advisors added 999,202 shares of BETA in the fourth quarter. The estimated value was $28.19 million. The transaction resulted in the BETA position accounting for 47.15% of the fund's reportable assets under manage…
Omada Health, Inc. SAN FRANCISCO, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 44th Annual J.P. Morg…
SAN FRANCISCO, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that members of senior management will participate in the 8th Annual Evercore Healthcare Conferenc…
Revenue of $68 million, up 49%; 53%Member Growth Significant Reduction in Net Loss and First Quarter of Positive Adjusted EBITDA Announces New GLP-1 Prescribing Offering SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health, Inc. (…
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual-first, between-visit health care provider, today announced the planned launch of its prescribing capability. After reporting 53% year-over-year membe…
SAN FRANCISCO, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its third quarter 2025 results on Thursday, November 6, 2025, after market cl…
A Relative Strength Rating upgrade for Omada Health shows improving technical performance. Will it continue? Continue Reading View Comments
Evercore ISI analyst Elizabeth Anderson added Omada Health (OMDA) to the firm’s “Tactical Outperform” list as the firm updates estimates and makes several tactical calls in the Healthcare Technology & Distribution group ahead of Q3 earning…